Hartwich, Patrick
4 results
Now showing 1 - 4 of 4
- Some of the metrics are blocked by yourconsent settings
Publication Access status: Open Access , Modulated-diameter zirconia nanotubes for controlled drug release - bye to the burstThe performance of an orthopedic procedure depends on several tandem functionalities. Such characteristics include materials’ surface properties and subsequent responses. Implant surfaces are typically roughened; this roughness can further be optimized to a specific morphology such as nanotubular roughness (ZrNTs) and the surfaces can further be used as static drug reservoirs. ZrNTs coatings are attracting interest due to their potential to improve the success rate of implant systems, by means of better physical affixation and also micro/nano physio-chemical interaction with the extracellular matrix(ECM). Effective control over the drug release properties from such coatings has been the subject of several published reports. In this study, a novel and simple approach to extending drug release time and limiting the undesirable burst release from zirconia nanotubes (ZrNTs) via structural modification was demonstrated. The latter involved fabricating a double-layered structure with a modulated diameter and was achieved by varying the voltage and time during electrochemical anodization. The structurally modified ZrNTs and their homogenous equivalents were characterized via SEM and ToF-SIMS, and their drug release properties were monitored and compared using UV–Vis spectroscopy. We report a significant reduction in the initial burst release phenomenon and enhanced overall release time. The simple structural modification of ZrNTs can successfully enhance drug release performance, allowing for flexibility in designing drug delivery coatings for specific implant challenges, and offering a new horizon for smart biomaterials based on metaloxide nanostructures.Source Type:Article154 114 - Some of the metrics are blocked by yourconsent settings
Publication Access status: Metadata only , Nanodentistry aspects explored towards nanostructured ZrO2: Immobilizing zirconium-oxide nanotube coatings onto zirconia ceramic implant surfacesWe report on a facile strategy to impart nanostructured morphology to commercially available ceramic-preforms used for biomedical applications in the field of dentistry. This process involves the deposition of nanotubular zirconium-oxide (ZrNT) membranes onto zirconia (ZrO2) ceramic discs at ambient conditions. ZrNTs are fabricated via electrochemical anodization of zirconium foil in a one-pot synthesis. The ZrNT film is detached from the metal-foil using office-adhesive tape and freestanding ZrNT films were obtained via dissolution of adhesives in a solvent bath, which also facilitate the transfer of ZrNT film onto the ceramic. This simple technique allows to impart a robust micro-nanoscale structure to bulk-ceramics that can potentially offer insights into designing ‘smart’ implants in the field of ceramic-biomaterial applications.Source Type:Article3 - Some of the metrics are blocked by yourconsent settings
Publication Access status: Metadata only , Preparation and Characterization of Transferable Encapsulated Dye-Sensitized Solar CellsThe increasing demand for sustainable energy as a means to combat the impact of climate change is addressed via a novel concept in the present work. Herein presented are developed transferable encapsulated dye-sensitized solar cells, canonically “solar capsules”, for photovoltaic applications on alternative surfaces, such as facades. The solar capsule assembly houses all the components necessary for photovoltaic energy conversion, enclosed within a semiconductor nanotubular array, making them truly unique in their construction. This capsule-style unit enables an easy transfer and draft onto a wide range of materials and surfaces for photovoltaic functionalization and applications. This type of dye-sensitized solar cell typically consists of transferred solar capsules and two additional electrodes. The design and construction of solar capsules means they have a high economic viability as they can seamlessly be up-scaled using commercially established techniques such as anodization and subsequent functionalization. This work demonstrates a working model of such transferable solar capsules by fabricating TiO2 nanotubes that are functionalized via facile dip- and spin-coating techniques in a wet lab at ambient conditions. These prototypes are characterized in bulk and are thoroughly investigated at the nanoscale for information on the chemical distribution of the constituents, as they may be influenced during the manufacturing process.Source Type:Article4 - Some of the metrics are blocked by yourconsent settings
Publication Access status: Open Access , Transcriptomic analysis of intracellular RNA granules and small extracellular vesicles: Unmasking their overlap in a cell model of Huntington's diseaseHuntington's disease (HD) arises from the abnormal expansion of a CAG repeat in the HTT gene. The mutant CAG repeat triggers aberrant RNA-protein interactions and translates into toxic aggregate-prone polyglutamine protein. These aberrant RNA-protein ineractions also seed the formation of cytoplasmic liquid-like granules, such as stress granules. Emerging evidence demonstrates that granules formed via liquid-liquid phase separation can mature into gel-like inclusions that persist within the cell and may act as precursor to aggregates that occur in patients' tissue. Thus, deregulation of RNA granules is an important component of neurodegeneration. Interestingly, both the formation of intracellular membrane-less organelles like stress granules and the secretion of small extracellular vesicles (sEVs) increase upon stress and under disease conditions. sEVs are lipid membrane-bound particles that are secreted from all cell types and may participate in the spreading of misfolded proteins and aberrant RNA-protein complexes across the central nervous system in neurodegenerative diseases like HD. In this study, we performed a comparative transcriptomic analysis of sEVs and RNA granules in an HD model. RNA granules and sEVs were isolated from an inducible HD cell model. Both sEVs and RNA granules were isolated from induced (HD) and non-induced (control) cells and analyzed by RNA sequencing. Our comparative analysis between the transcriptomics data of HD RNA granules and sEVs showed that: (I) intracellular RNA granules and extracellular RNA vesicles share content, (II) several non-coding RNAs translocate to RNA granules, and (III) the composition of RNA granules and sEVs is affected in HD cells. Our data showing common transcripts in intracellular RNA granules and extracellular sEVs suggest that formation of RNA granules and sEV loading may be related. Moreover, we found a high abundance of lncRNAs in both control and HD samples, with several transcripts under REST regulation, highlighting their potential role in HD pathogenesis and selective incorporation into sEVs. The transcriptome cargo of RNA granules or sEVs may serve as a source for diagnostic strategies. For example, disease-specific RNA-signatures of sEVs can serve as biomarker of central nervous system diseases. Therefore, we compared our dataset to transcriptomic data from HD patient sEVs in blood. However, our data suggest that the cell-type specific signature of sEV-secreted RNAs as well as their high variability may make it difficult to detect these biomarkers in blood.Source Type:Article32 51
